Trial
NCT03566511
Use of Functional MRI to Assess Functional Hypothalamic Activation in Response to Diazoxide
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Meredith Hawkins
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); American Diabetes Association
Condition
Diabetes Mellitus, Type 2
Intervention
Diazoxide
Why stopped
Grant funding ended. NIDDK grant renewed without an MR aim. No plans to do future studies.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-05-31